Avalo Therapeutics (AVTX) Price to Earnings (2017 - 2025)
Avalo Therapeutics' Price to Earnings came in at 1.19 for Q1 2025.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Price to Earnings (2017 - 2025) Analysis & Trends
For FY2017, Avalo Therapeutics' Price to Earnings was 19.17.
- The Q1 2025 figure represents the highest quarterly Price to Earnings since Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Avalo Therapeutics | 653.59 Mn | 653.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 1.19 |
| Jun 30, 2018 | 25.57 |
| Mar 31, 2018 | 13.56 |
| Dec 31, 2017 | 12.55 |
| Sep 30, 2017 | 3.64 |
API Access
Avalo Therapeutics Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();